Johnson & Johnson ($JNJ) Third Quarter Profit Declines 9 Percent, Cuts Outlook

22

Today, before market open, Johnson & Johnson (NYSE: JNJ) disclosed its earnings, giving investors a glimpse into the company’s performance during the third quarter.

The revenues totaling $22.47 billion, beat market predicted $22.16 billion for the quarter.

During the quarter the firm recorded an adjusted income of $2.42 per share, exceeded the wall street anticipated $2.21 profit per share.

The quarterly net income reported by the company, amounting to $1.11 per share on a GAAP basis, signifies a 34.3 percent drop from the results of the previous year’s comparable period.

Period EPS
Actual
EPS
Growth*
Revenue
Actual
Revenue
Growth*
Q3 2024 $2.42 -9.0% 22.47 B +5.2%
Historical Earnings Insight
Q2 2024 $2.82 +0.7% 22.45 B -12.1%
Q1 2024 $2.71 +1.1% 21.38 B -13.6%
Q4 2023 $2.29 -2.6% 21.40 B -9.7%
Q3 2023 $2.66 +4.3% 21.35 B -10.3%
Q2 2023 $2.80 +8.1% 25.53 B +6.3%
*Growth on year-over-year basis

 
The diluted earnings declined 9.02 percent, while revenues grew 5.25 percent when looking at the identical quarter of preceding year.

JNJ has revised its expected earnings for full year 2024. The updated forecast now shows a range of $9.88 to $9.98 per share, compared to the prior range of $9.97 to $10.07 per share.

at Further the company has revised its revenue forecast for full year 2024, updating the range from $88.00 to $88.40 billion to a newly estimated range of $88.4 to $88.80 billion.

Conversely financial analysts on Wall Street expect a revenue of $88.67 billion and earnings of $9.91 per share

Period Type Company
Outlook
Analysts
Estimate
Company
Vs.*
Analysts
FY 2024 EPS $9.88~$9.98 $9.91 0.2%
REV $88.4 B~$88.8 B $88.67 B -0.1%
*Based on mid-point

 
During Monday’s trading, Johnson & Johnson (JNJ) shares reached a low of $160.90 and a high of $162.14, along with a total volume of 5.96 million shares. The stock ended the regular trading session at $161.60, demonstrating an upturn of 0.09 percent.